MedPath

Vexa

Vexa-D

Approved
Approval ID

85933294-59de-4465-a02c-4225f0c20ce8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2015

Manufacturers
FDA

Pharmaceutics Corporation

DUNS: 079132026

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine, Allantoin, Petrolatum

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49430-053
Product Classification
G
Generic Name
Lidocaine, Allantoin, Petrolatum
Product Specifications
Route of AdministrationTOPICAL
Effective DateMarch 20, 2015
FDA Product Classification

INGREDIENTS (5)

ALLANTOINActive
Quantity: 2 mg in 1 1
Code: 344S277G0Z
Classification: ACTIB
LIDOCAINEActive
Quantity: 4 mg in 1 1
Code: 98PI200987
Classification: ACTIB
PETROLATUMActive
Quantity: 30 mg in 1 1
Code: 4T6H12BN9U
Classification: ACTIB
ONIONInactive
Code: 492225Q21H
Classification: IACT
.ALPHA.-TOCOPHEROLInactive
Code: H4N855PNZ1
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vexa - FDA Drug Approval Details